Vaxxinity Stock Technical Analysis
| VAXX Stock | USD 0.02 0.01 73.00% |
As of the 10th of February, Vaxxinity has the Semi Deviation of 121.78, coefficient of variation of 333.91, and Risk Adjusted Performance of 0.2502. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vaxxinity, as well as the relationship between them.
Vaxxinity Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vaxxinity, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VaxxinityVaxxinity |
Vaxxinity 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vaxxinity's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vaxxinity.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Vaxxinity on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Vaxxinity or generate 0.0% return on investment in Vaxxinity over 90 days. Vaxxinity is related to or competes with Orphazyme A/S. Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurol... More
Vaxxinity Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vaxxinity's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vaxxinity upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 83.27 | |||
| Information Ratio | 0.2995 | |||
| Maximum Drawdown | 22255.16 | |||
| Value At Risk | (99.00) | |||
| Potential Upside | 14900.0 |
Vaxxinity Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vaxxinity's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vaxxinity's standard deviation. In reality, there are many statistical measures that can use Vaxxinity historical prices to predict the future Vaxxinity's volatility.| Risk Adjusted Performance | 0.2502 | |||
| Jensen Alpha | 1326.63 | |||
| Total Risk Alpha | 788.58 | |||
| Sortino Ratio | 14.98 | |||
| Treynor Ratio | (1.39) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vaxxinity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vaxxinity February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2502 | |||
| Market Risk Adjusted Performance | (1.38) | |||
| Mean Deviation | 2183.25 | |||
| Semi Deviation | 121.78 | |||
| Downside Deviation | 83.27 | |||
| Coefficient Of Variation | 333.91 | |||
| Standard Deviation | 4164.67 | |||
| Variance | 1.734448997E7 | |||
| Information Ratio | 0.2995 | |||
| Jensen Alpha | 1326.63 | |||
| Total Risk Alpha | 788.58 | |||
| Sortino Ratio | 14.98 | |||
| Treynor Ratio | (1.39) | |||
| Maximum Drawdown | 22255.16 | |||
| Value At Risk | (99.00) | |||
| Potential Upside | 14900.0 | |||
| Downside Variance | 6933.67 | |||
| Semi Variance | 14830.88 | |||
| Expected Short fall | (5,552) | |||
| Skewness | 3.71 | |||
| Kurtosis | 13.57 |
Vaxxinity Backtested Returns
Vaxxinity is out of control given 3 months investment horizon. Vaxxinity owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.33, which indicates the firm had a 0.33 % return per unit of risk over the last 3 months. We have analyzed and interpolated twenty-seven different technical indicators, which can help you to evaluate if expected returns of 109.7% are justified by taking the suggested risk. Use Vaxxinity Semi Deviation of 121.78, risk adjusted performance of 0.2502, and Coefficient Of Variation of 333.91 to evaluate company specific risk that cannot be diversified away. Vaxxinity holds a performance score of 26 on a scale of zero to a hundred. The entity has a beta of -898.97, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Vaxxinity are expected to decrease by larger amounts. On the other hand, during market turmoil, Vaxxinity is expected to outperform it. Use Vaxxinity maximum drawdown, skewness, as well as the relationship between the Skewness and price action indicator , to analyze future returns on Vaxxinity.
Auto-correlation | 0.17 |
Very weak predictability
Vaxxinity has very weak predictability. Overlapping area represents the amount of predictability between Vaxxinity time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vaxxinity price movement. The serial correlation of 0.17 indicates that over 17.0% of current Vaxxinity price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Vaxxinity technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Vaxxinity Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Vaxxinity across different markets.
About Vaxxinity Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vaxxinity on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vaxxinity based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vaxxinity price pattern first instead of the macroeconomic environment surrounding Vaxxinity. By analyzing Vaxxinity's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vaxxinity's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vaxxinity specific price patterns or momentum indicators. Please read more on our technical analysis page.
Vaxxinity February 10, 2026 Technical Indicators
Most technical analysis of Vaxxinity help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vaxxinity from various momentum indicators to cycle indicators. When you analyze Vaxxinity charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2502 | |||
| Market Risk Adjusted Performance | (1.38) | |||
| Mean Deviation | 2183.25 | |||
| Semi Deviation | 121.78 | |||
| Downside Deviation | 83.27 | |||
| Coefficient Of Variation | 333.91 | |||
| Standard Deviation | 4164.67 | |||
| Variance | 1.734448997E7 | |||
| Information Ratio | 0.2995 | |||
| Jensen Alpha | 1326.63 | |||
| Total Risk Alpha | 788.58 | |||
| Sortino Ratio | 14.98 | |||
| Treynor Ratio | (1.39) | |||
| Maximum Drawdown | 22255.16 | |||
| Value At Risk | (99.00) | |||
| Potential Upside | 14900.0 | |||
| Downside Variance | 6933.67 | |||
| Semi Variance | 14830.88 | |||
| Expected Short fall | (5,552) | |||
| Skewness | 3.71 | |||
| Kurtosis | 13.57 |
Vaxxinity February 10, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Vaxxinity stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | Huge | ||
| Rate Of Daily Change | 1.73 | ||
| Day Median Price | 0.02 | ||
| Day Typical Price | 0.02 | ||
| Price Action Indicator | 0.00 |
Additional Tools for Vaxxinity Pink Sheet Analysis
When running Vaxxinity's price analysis, check to measure Vaxxinity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxxinity is operating at the current time. Most of Vaxxinity's value examination focuses on studying past and present price action to predict the probability of Vaxxinity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxxinity's price. Additionally, you may evaluate how the addition of Vaxxinity to your portfolios can decrease your overall portfolio volatility.